ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)
NCT02093741
·
clinicaltrials.gov ↗
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia A
Congenital Factor VIII (FVIII) Deficiency
Interventions
BIOLOGICAL:
Octocog alfa (recombinant human coagulation factor VIII) [ADVATE]
Sponsor
Baxalta now part of Shire